Global artificial intelligence (AI) spending is projected to rise significantly in the coming years, with UBS estimating a 60 per cent year-on-year increase in 2025, to USD 360 billion. The momentum ...

U.S. tariffs present not only a risk of Canadian job losses - and loss of access to employer-sponsored drug plans - but also the risk of higher prescription drug prices.